Incorrect in so many ways.
ns has multiple products and multiple customers.
it is already making a health profit with all that advertising and rebates you suggest.
most manufacturers do not want the expense of setting up their own distribution network especially in a small market.
ns will go into its own manufacturing. Be it on behalf of current products through license or similar product.
this will allow for the current tech to be incorporated.
- Forums
- ASX - By Stock
- WFL
- Understanding the deal
Understanding the deal, page-70
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online